Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL2522513

CCOC(=O)c1cc2n(c1)CCCNC2.O=C(O)C(F)(F)F

nearest known ligand 0.36

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 6/20 0.36
▸ NPC1 O15118 2/20 0.35
▸ RAB9A P51151 2/20 0.35
▸ MEN1 O00255 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ PKM P14618 1/20 0.35
▸ DPP4 P27487 2/20 0.35
▸ DPP7 Q9UHL4 2/20 0.35
▸ HPGD P15428 2/20 0.34
▸ KDM4E B2RXH2 3/20 0.34
▸ HSD17B10 Q99714 3/20 0.34
▸ ALOX15 P16050 2/20 0.34
▸ SMN1; SMN2 Q16637 2/20 0.34
▸ ALOX5 P09917 1/20 0.34
▸ MAPT P10636 1/20 0.34
▸ L3MBTL1 Q9Y468 1/20 0.34
▸ ACHE P22303 2/20 0.33
▸ CA12 O43570 1/20 0.33
▸ CA1 P00915 1/20 0.33
▸ CA2 P00918 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL2519975 0.93 ALDH1A1 (0.39) ALDH1A1PKMDPP4DPP7HPGD
SCHEMBL12211189 0.92 RAB9A (0.40) ALDH1A1NPC1RAB9AMEN1KMT2A
SCHEMBL2519720 0.84 CA12 (0.41) ALDH1A1NPC1RAB9AMEN1KMT2A
Hydrochloric Acid SCHEMBL30782373 0.83 CA12 (0.40) ALDH1A1NPC1RAB9AMEN1KMT2A
SCHEMBL25318763 0.74 RAB9A (0.45) ALDH1A1NPC1RAB9AMEN1KMT2A
SCHEMBL12271733 0.70 ALOX5 (0.43) ALDH1A1NPC1RAB9AMEN1KMT2A
SCHEMBL12283351 0.70 HDAC6 (0.47) —
SCHEMBL2521094 0.69 RPS6KA3 (0.43) ALDH1A1NPC1RAB9AMEN1KMT2A
Trifluoroacetic Acid SCHEMBL23778373 0.69 TSHR (0.44) ALDH1A1MEN1KMT2APKMDPP4
SCHEMBL12283967 0.68 CYP2C9 (0.45) ALDH1A1RAB9AHPGDKDM4EHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150175614-A1 SUBSTITUTED HYDROXAMIC ACIDS AND USES THEREOF MILLENNIUM PHARMACEUTICALS, INC. 2015-06-25 — — US disclosed
US-8946223-B2 Substituted hydroxamic acids and uses thereof MILLENNIUM PHARMACEUTICALS, INC. (US) 2015-02-03 — — US disclosed
WO-2011130163-A1 SUBSTITUTED HYDROXAMIC ACIDS AND USES THEREOF MILLENNIUM PHARMACEUTICALS, INC. (US) 2011-10-20 — — WO disclosed
US-20110251184-A1 SUBSTITUTED HYDROXAMIC ACIDS AND USES THEREOF MILLENNIUM PHARMACEUTICALS, INC. (US) 2011-10-13 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150175614-A1 SUBSTITUTED HYDROXAMIC ACIDS AND USES THEREOF HDAC6, HDAC1, H1-3 ALDH1A1 828/4885NPC1 2742/4885RAB9A 1951/4885
US-20110251184-A1 SUBSTITUTED HYDROXAMIC ACIDS AND USES THEREOF HDAC6, HDAC1, H1-3 ALDH1A1 828/4885NPC1 2742/4885RAB9A 1951/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback